Determining Factors for the Reduction of Dopaminergic Drugs after Bilateral Subthalamic Nucleus Deep Brain Stimulation

Sung-Reul KIM; Sun-Ju CHUNG; Tai-Yeon LEE; Mi-Jung KIM; Mi-Sun KIM; Myoung-Chong LEE.
Journal of the Korean Neurological Association ; : 8-13, 2008.
Artículo en Ko | WPRIM | ID: wpr-30343

Documentos relacionados

  1. Functional connectivity maps of theta/alpha and beta coherence within the subthalamic nucleus region.
  2. Long-Term Recording of Subthalamic Aperiodic Activities and Beta Bursts in Parkinson's Disease.
  3. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
  4. Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
  5. Changing Gears - DBS For Dopaminergic Desensitization in Parkinson's Disease?
  6. [Intolerance to dopaminergic medication and deep brain stimulation: A report of 3 cases].
  7. Subthalamic deep brain stimulation under general anesthesia and neurophysiological guidance while on dopaminergic medication: comparative cohort study.
  8. Uncoupling of dopaminergic and subthalamic stimulation: Life-threatening DBS withdrawal syndrome.
  9. Subthalamic nucleus-language network connectivity predicts dopaminergic modulation of speech function in Parkinson's disease.
  10. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.